Skip to content

Mechanism of Pacemaker Induced Left Ventricular Dysfunction

Mechanism of Pacemaker Induced Left Ventricular Dysfunction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20210321003
Enrollment
240
Registered
2021-03-21
Start date
2021-04-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pacemaker induced left ventricular dysfunction pacemaker induced left ventricular dysfunction

Interventions

Patients with total AV block who experience LV dysfunction due to right ventricular septal pacemaker implantation as assessed by GLS at 1 and 3 months
Basic Science
left ventricular dysfunction

Sponsors

Self-funded
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Male or female aged >18 years old that was diagnosed with total AV block and will be implanted with a permanent pacemaker in the right ventricular septum 2. EF >50% and TAPSE >16 mm 3. Agree for follow up after pacemaker implantation 4. Written informed consent obtained from the patient

Exclusion criteria

Exclusion criteria: 1. Pregnancy 2. Myocardial infarction or revascularization therapy in the last 3 months 3. Permanent AF 4. Heart valve disease with significant hemodynamic consequences 5. Abnormal heart structure changes including the right atrium, left atrium, right ventricle, or left ventricle dilation. 6. NYHA function class III or IV 7. Significant respiratory disease 8. Carcinoma in the last 5 years 9. Autoimmune disease

Design outcomes

Primary

MeasureTime frame
biomarker level changes in patients with total AV block who experienced LV dysfunction due to right ventricular septal pacemaker implantation as assessed by GLS at 1 and 3 months 1 and 3 months ELISA and RT-qPCR

Secondary

MeasureTime frame
difference in biomarker levels between patients with total AV block who experience and do not experience LV dysfunction due to right ventricular septal pacemaker implantattion assessed by GLS 1 and 3 months ELISA and RT-qPCR

Countries

Indonesia

Contacts

Public ContactSidhi Laksono

Faculty of Medicine, University of Indonesia

sidhilaksono@uhamka.ac.id628111585599

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026